Eluciderm

San Diego, United States Founded: 2018 • Age: 8 yrs
Creates topical compounds to accelerate wound healing and reduce scarring.

About Eluciderm

Eluciderm is a company based in San Diego (United States) founded in 2018. It operates as a B2B. Eluciderm offers products and services including ELU42. Eluciderm operates in a competitive market with competitors including Ilya Pharma, QBiotics, MediWound, Resolution Therapeutics and SanuWave, among others.

  • Headquarter San Diego, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Eluciderm, Inc
Operational Areas
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Eluciderm

Eluciderm offers a comprehensive portfolio of products and services, including ELU42. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Drug that accelerates wound healing and reduces scarring.

Funding Insights of Eluciderm

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Eluciderm

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Eluciderm

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Eluciderm Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Eluciderm

Eluciderm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ilya Pharma, QBiotics, MediWound, Resolution Therapeutics and SanuWave, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Biological drugs for skin and mucosa wound treatment are developed.
domain founded_year HQ Location
Small molecules from plant extracts are developed for medical applications.
domain founded_year HQ Location
Enzymatic therapies for tissue repair and regeneration are developed.
domain founded_year HQ Location
Macrophage cell therapies are developed for inflammatory and liver diseases.
domain founded_year HQ Location
Noninvasive devices and biologics for wound healing are developed.
domain founded_year HQ Location
Regenerative biomaterials for wounds are developed using particle technology.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Eluciderm

Frequently Asked Questions about Eluciderm

When was Eluciderm founded?

Eluciderm was founded in 2018.

Where is Eluciderm located?

Eluciderm is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

What does Eluciderm do?

Eluciderm is a biotechnology company based in San Diego, USA, that develops innovative topical therapeutics to enhance wound healing for various conditions. Their products regenerate skin for burn victims, diabetic patients, and surgery recipients by promoting faster recovery with superior strength and elasticity. The company focuses on accessible, non-invasive treatments that minimize scarring and improve outcomes, targeting global markets through pharmaceutical strategies.

Who are the top competitors of Eluciderm?

Eluciderm's top competitors include Ilya Pharma, SanuWave and QBiotics.

What products or services does Eluciderm offer?

Eluciderm offers ELU42.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available